Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Buy
+6,700
New +$2.29M 0.06% 185
2025
Q4
Sell
-123,500
Closed -$34.8M 1223
2025
Q3
$34.8M Buy
123,500
+52,800
+75% +$15.3M 0.64% 23
2025
Q2
$19.7M Buy
70,700
+32,400
+85% +$9.18M 0.45% 35
2025
Q1
$11.9M Buy
+38,300
New +$11.3M 0.33% 46

Other funds holding AMGN

DRW Securities's AMGN Position: Q2 2026 in Review

DRW Securities increased its Amgen (AMGN) stake by 345% in Q2 2026, buying an estimated $904K and bringing the position to 3,407 shares worth $1.23M. The position accounts for 0.03% of the portfolio, ranked #270.

DRW Securities first reported a position in AMGN in Q4 2017 and has held it in 13 quarters since. The position peaked at $11.4M in Q3 2025. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • DRW Securities held 3,407 shares of Amgen worth $1.23M as of Q2 2026.
  • DRW Securities bought 2,642 Amgen shares in Q2 2026, an estimated $904K.
  • Amgen made up 0.03% of DRW Securities's portfolio in Q2 2026, its #270 holding.
  • DRW Securities first reported a position in Amgen in Q4 2017 and has held it in 13 quarters since.
  • DRW Securities's Amgen position peaked at $11.4M in Q3 2025.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.